0000950170-24-063022.txt : 20240521
0000950170-24-063022.hdr.sgml : 20240521
20240521165509
ACCESSION NUMBER: 0000950170-24-063022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240517
FILED AS OF DATE: 20240521
DATE AS OF CHANGE: 20240521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Honore Tage
CENTRAL INDEX KEY: 0001967946
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34186
FILM NUMBER: 24970313
MAIL ADDRESS:
STREET 1: C/O VANDA PHARMACEUTICALS INC.
STREET 2: 2200 PENNSYLVANIA AVENUE, SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001347178
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 030491827
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
BUSINESS PHONE: 202-734-3400
MAIL ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
4
1
ownership.xml
4
X0508
4
2024-05-17
0001347178
Vanda Pharmaceuticals Inc.
VNDA
0001967946
Honore Tage
C/O VANDA PHARMACEUTICALS INC.
2200 PENNSYLVANIA AVENUE, SUITE 300E
WASHINGTON
DC
20037
true
false
false
false
false
Common Stock
2024-05-17
4
A
false
20529
0
A
64244
D
Stock Option (right to buy)
5.48
2024-05-17
4
A
false
37578
0
A
2034-05-16
Common Stock
37578
37578
D
Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
This option vests and becomes exercisable with respect to 100% of the option shares on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
/s/ Tage Honore
2024-05-21